Search alternatives:
significant greatest » significant treatment (Expand Search), significant rates (Expand Search), significantly greater (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
point decrease » point increase (Expand Search)
significant greatest » significant treatment (Expand Search), significant rates (Expand Search), significantly greater (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
point decrease » point increase (Expand Search)
-
21
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
22
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
23
-
24
-
25
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
26
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
27
-
28
-
29
-
30
-
31
-
32
MiR-129-5p levels were decreased in mouse depression models.
Published 2025“…The Y-axis represents the fold change, while the X-axis indicates the significance of differential expression. The gray points represent miRNAs with no significant change (p < 0.05, false discovery rate (FDR) q < 0.05), while red and blue points indicate upregulated and downregulated miRNAs (p < 0.05, FDR q < 0.05), respectively. …”
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40